Mylan, Others To Pay $124M Over Medicaid Rebates
Mylan Inc. and several other pharmaceutical companies will pay a combined sum of $124 million to settle allegations that they bilked state Medicaid programs of millions of dollars by improperly classifying...To view the full article, register now.
Already a subscriber? Click here to view full article